What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
Zobair M. Younossi mainly investigates Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Fatty liver and Chronic liver disease.
His study in Liver disease, Cirrhosis, Hepatology, Metabolic syndrome and Fibrosis are all subfields of Internal medicine.
His Gastroenterology research includes elements of Diabetes mellitus, Liver transplantation and Ribavirin.
His studies deal with areas such as Steatosis, Obesity, Liver biopsy and Type 2 diabetes as well as Nonalcoholic fatty liver disease.
His studies in Fatty liver integrate themes in fields like Body mass index, Endocrinology and Cohort.
His biological study spans a wide range of topics, including Prevalence, Epidemiology, Incidence, Quality of life and Physical therapy.
His most cited work include:
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes (3129 citations)
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes (3129 citations)
- Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. (2709 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Gastroenterology, Fatty liver, Hepatitis C and Chronic liver disease.
His research in Internal medicine focuses on subjects like Ribavirin, which are connected to Regimen.
His work on Steatosis as part of general Gastroenterology study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His work carried out in the field of Fatty liver brings together such families of science as Endocrinology, Obesity and Metabolic syndrome.
His Chronic liver disease research is multidisciplinary, relying on both Body mass index and Physical therapy.
His Nonalcoholic fatty liver disease research incorporates elements of Liver biopsy, Type 2 diabetes and Insulin resistance.
He most often published in these fields:
- Internal medicine (98.13%)
- Gastroenterology (47.98%)
- Fatty liver (36.32%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (98.13%)
- Gastroenterology (47.98%)
- Nonalcoholic fatty liver disease (21.67%)
In recent papers he was focusing on the following fields of study:
Zobair M. Younossi mainly focuses on Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Fatty liver and Chronic liver disease.
His Cirrhosis, Liver disease, Non alcoholic and Steatohepatitis study in the realm of Internal medicine connects with subjects such as In patient.
Zobair M. Younossi combines subjects such as Fibrosis, Hepatocellular carcinoma, Nonalcoholic steatohepatitis and Hepatitis C with his study of Gastroenterology.
The various areas that Zobair M. Younossi examines in his Nonalcoholic fatty liver disease study include Diabetes mellitus, Metabolic syndrome, Type 2 diabetes, Mortality rate and National Health and Nutrition Examination Survey.
His Fatty liver research includes themes of Body mass index and Prevalence, Epidemiology.
The study incorporates disciplines such as Overweight, Liver transplantation, Hepatology and Intensive care medicine in addition to Chronic liver disease.
Between 2018 and 2021, his most popular works were:
- Non-alcoholic fatty liver disease - A global public health perspective. (392 citations)
- Non-alcoholic fatty liver disease - A global public health perspective. (392 citations)
- Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis (309 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
His primary areas of study are Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Cirrhosis and Fatty liver.
His is doing research in Liver disease, Chronic liver disease, Disease, Body mass index and Epidemiology, both of which are found in Internal medicine.
The Nonalcoholic fatty liver disease study combines topics in areas such as Diabetes mellitus, Metabolic syndrome, Mortality rate, Hazard ratio and National Health and Nutrition Examination Survey.
Zobair M. Younossi has researched Gastroenterology in several fields, including Liver transplantation, Hepatitis C, Liver cancer, Hepatocellular carcinoma and Proportional hazards model.
His Cirrhosis study combines topics in areas such as Fibrosis, Placebo, Steatohepatitis and Hepatitis C virus.
His Fatty liver research is multidisciplinary, incorporating elements of Odds ratio, Hepatology, Disease burden and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
